OK
Industry News

Twelve and LanzaTech Partner to Produce Polypropylene Using CO2 Emissions

Published on 2021-09-06. Edited By : SpecialChem

TAGS:  Sustainability and Bioplastics    Medical   

twelve-co2-pp Twelve and LanzaTech have partnered to transform CO2 emissions into polypropylene, a key polymer used for medical devices including syringes and IV bags, as well as for large-scale applications in automotive, furniture, textiles and other everyday products.

Replacing Petrochemicals in Products


Twelve’s carbon transformation technology converts CO2 into materials that are traditionally made from fossil fuels. The company helps brands eliminate emissions by replacing the petrochemicals in their products and supply chains with CO2Made® carbon negative chemicals and materials, as well as carbon neutral fuels.

LanzaTech’s carbon recycling Pollution To Products™ technology uses nature-based solutions to produce ethanol and other materials from waste carbon sources. The partnership will bring together the two platform technologies to enable additional product development from CO2 streams, representing just one of many pathways to scale carbon transformation solutions.

New Way to Produce Polypropylene


“Polypropylene is a key material for essential medical supplies and for many products we rely on in our daily lives. Today, 100 percent of new polypropylene in use worldwide is made from petrochemicals. We now have a way to produce this critical material from CO2 and water instead of from fossil fuels, with no tradeoffs in quality, efficacy, or performance. Replacing all of the world’s fossil polypropylene production with CO2Made® polypropylene would reduce carbon emissions by an estimated 700 million tons per year or more,” said Twelve Chief Science Officer, Dr. Etosha Cave.

“By harnessing biology, we can leverage the power of nature to solve a very modern problem. The overabundance of CO2 in our atmosphere has pushed our planet into a state of emergency. We need all carbon transformation solutions to turn this liability into an opportunity, keeping fossil resources in the ground, and our climate safe for everyone,” said LanzaTech CEO, Dr. Jennifer Holmgren.

To pursue the partnership, Twelve and LanzaTech have been awarded a $200,000 grant from Impact Squared, a $1.1 million fund that was designed and launched by British universal bank Barclays and Unreasonable, a catalytic platform for entrepreneurs tackling some of the world’s most pressing challenges. With the Impact Squared grant, Twelve and LanzaTech are taking a collaborative approach to reducing the fossil fuel impact of essential products.

Source: LanzaTech

subscribe-SB-channelmedical-channel-susbcription


Channel Alerts

Receive weekly digests on hot topics

Back to Top